ReGen Therapeutics Plc
29-30 Margaret Street
Langham House, Suite 406
London
W1W 8SA
United Kingdom
Tel: 44-20-7907-0910
Fax: 44-20-7907-0911
Website: http://www.regentherapeutics.com/
4 articles about ReGen Therapeutics Plc
-
Regeneron, ReGen Therapeutics Plc Eczema Drug Dupilumab Gets FDA Breakthrough Therapy Designation
11/24/2014
-
ReGen Therapeutics Plc Joins International OTCQX
7/14/2008
-
ReGen Therapeutics Plc Release: Anti-SDF-1 Treatment Prevents Retinal Neovascularization; RegenMed Study May Lead To Novel Therapy For Diabetic Retinopathy
2/14/2006
-
ReGen's Colostrinin Increases Cell Lifespan
9/28/2005